JP5241503B2 - 包装材 - Google Patents

包装材 Download PDF

Info

Publication number: JP5241503B2
Authority: JP; Japan
Prior art keywords: layer; packaging material; density polyethylene; pack; press
Prior art date: 2006-10-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

JP2008540976A

Other languages

English (en)

Japanese (ja)

Other versions

JPWO2008050714A1 (ja

Inventor

正昭高橋

恭彦佐藤

達也小川

真一小泉

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Daiichi Sankyo Co Ltd

Original Assignee

Daiichi Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-25

Filing date

2007-10-22

Publication date

2013-07-17

2007-10-22 Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd

2007-10-22 Priority to JP2008540976A priority Critical patent/JP5241503B2/ja

2010-02-25 Publication of JPWO2008050714A1 publication Critical patent/JPWO2008050714A1/ja

2013-07-17 Application granted granted Critical

2013-07-17 Publication of JP5241503B2 publication Critical patent/JP5241503B2/ja

Status Active legal-status Critical Current

2027-10-22 Anticipated expiration legal-status Critical

Links

239000005022 packaging material Substances 0.000 title claims description 55
239000010410 layer Substances 0.000 claims description 100
238000001179 sorption measurement Methods 0.000 claims description 53
HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 41
229910021536 Zeolite Inorganic materials 0.000 claims description 39
239000010457 zeolite Substances 0.000 claims description 39
239000003463 adsorbent Substances 0.000 claims description 33
239000000463 material Substances 0.000 claims description 29
-1 polypropylene Polymers 0.000 claims description 29
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 28
239000004743 Polypropylene Substances 0.000 claims description 26
229920001155 polypropylene Polymers 0.000 claims description 26
UQGKUQLKSCSZGY-UHFFFAOYSA-N Olmesartan medoxomil Chemical compound C=1C=C(C=2C(=CC=CC=2)C2=NNN=N2)C=CC=1CN1C(CCC)=NC(C(C)(C)O)=C1C(=O)OCC=1OC(=O)OC=1C UQGKUQLKSCSZGY-UHFFFAOYSA-N 0.000 claims description 24
229960001199 olmesartan medoxomil Drugs 0.000 claims description 24
229920001684 low density polyethylene Polymers 0.000 claims description 23
239000004702 low-density polyethylene Substances 0.000 claims description 23
239000002051 C09CA08 - Olmesartan medoxomil Substances 0.000 claims description 22
229920000092 linear low density polyethylene Polymers 0.000 claims description 18
239000004707 linear low-density polyethylene Substances 0.000 claims description 18
239000000565 sealant Substances 0.000 claims description 13
239000000377 silicon dioxide Substances 0.000 claims description 12
150000001875 compounds Chemical class 0.000 claims description 11
239000012790 adhesive layer Substances 0.000 claims description 9
230000002209 hydrophobic effect Effects 0.000 claims description 9
238000004806 packaging method and process Methods 0.000 claims description 9
239000004800 polyvinyl chloride Substances 0.000 claims description 8
229920000915 polyvinyl chloride Polymers 0.000 claims description 7
235000019645 odor Nutrition 0.000 description 43
238000002360 preparation method Methods 0.000 description 33
238000000034 method Methods 0.000 description 26
229920005989 resin Polymers 0.000 description 18
239000011347 resin Substances 0.000 description 18
239000000126 substance Substances 0.000 description 14
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 9
125000002541 furyl group Chemical group 0.000 description 9
229910052782 aluminium Inorganic materials 0.000 description 7
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 7
239000000049 pigment Substances 0.000 description 7
239000011148 porous material Substances 0.000 description 7
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
239000003814 drug Substances 0.000 description 6
239000005038 ethylene vinyl acetate Substances 0.000 description 6
238000009472 formulation Methods 0.000 description 6
238000003475 lamination Methods 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
239000000203 mixture Substances 0.000 description 6
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 6
238000012360 testing method Methods 0.000 description 6
229920000089 Cyclic olefin copolymer Polymers 0.000 description 5
239000004713 Cyclic olefin copolymer Substances 0.000 description 5
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 5
238000001125 extrusion Methods 0.000 description 5
239000005033 polyvinylidene chloride Substances 0.000 description 5
229920005992 thermoplastic resin Polymers 0.000 description 5
239000004594 Masterbatch (MB) Substances 0.000 description 4
229920001328 Polyvinylidene chloride Polymers 0.000 description 4
238000010521 absorption reaction Methods 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
239000000853 adhesive Substances 0.000 description 4
230000001070 adhesive effect Effects 0.000 description 4
229920001577 copolymer Polymers 0.000 description 4
238000009820 dry lamination Methods 0.000 description 4
229920006242 ethylene acrylic acid copolymer Polymers 0.000 description 4
238000011156 evaluation Methods 0.000 description 4
239000011888 foil Substances 0.000 description 4
HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 4
206010020772 Hypertension Diseases 0.000 description 3
239000004952 Polyamide Substances 0.000 description 3
239000004698 Polyethylene Substances 0.000 description 3
230000004888 barrier function Effects 0.000 description 3
229920006228 ethylene acrylate copolymer Polymers 0.000 description 3
229920005648 ethylene methacrylic acid copolymer Polymers 0.000 description 3
229920006225 ethylene-methyl acrylate Polymers 0.000 description 3
229920005680 ethylene-methyl methacrylate copolymer Polymers 0.000 description 3
239000007789 gas Substances 0.000 description 3
239000008187 granular material Substances 0.000 description 3
238000010030 laminating Methods 0.000 description 3
238000002844 melting Methods 0.000 description 3
230000008018 melting Effects 0.000 description 3
229920002647 polyamide Polymers 0.000 description 3
229920000728 polyester Polymers 0.000 description 3
229920000573 polyethylene Polymers 0.000 description 3
239000004576 sand Substances 0.000 description 3
230000001953 sensory effect Effects 0.000 description 3
239000000758 substrate Substances 0.000 description 3
229920001342 Bakelite® Polymers 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
229960004916 benidipine Drugs 0.000 description 2
QZVNQOLPLYWLHQ-ZEQKJWHPSA-N benidipine Chemical compound C1([C@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)O[C@H]2CN(CC=3C=CC=CC=3)CCC2)=CC=CC([N+]([O-])=O)=C1 QZVNQOLPLYWLHQ-ZEQKJWHPSA-N 0.000 description 2
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
208000026106 cerebrovascular disease Diseases 0.000 description 2
208000020832 chronic kidney disease Diseases 0.000 description 2
239000002131 composite material Substances 0.000 description 2
230000007423 decrease Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000001035 drying Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
PEPQUBUZFYZZET-UHFFFAOYSA-N ethene;prop-2-enoic acid Chemical compound C=C.C=C.OC(=O)C=C PEPQUBUZFYZZET-UHFFFAOYSA-N 0.000 description 2
238000011049 filling Methods 0.000 description 2
235000013305 food Nutrition 0.000 description 2
238000011990 functional testing Methods 0.000 description 2
241000411851 herbal medicine Species 0.000 description 2
229920000554 ionomer Polymers 0.000 description 2
239000005001 laminate film Substances 0.000 description 2
239000000155 melt Substances 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
239000002245 particle Substances 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
125000005541 phosphonamide group Chemical group 0.000 description 2
229960005095 pioglitazone Drugs 0.000 description 2
239000004417 polycarbonate Substances 0.000 description 2
229920000515 polycarbonate Polymers 0.000 description 2
239000000843 powder Substances 0.000 description 2
238000009823 thermal lamination Methods 0.000 description 2
238000009816 wet lamination Methods 0.000 description 2
VUAFHZCUKUDDBC-SCSAIBSYSA-N (2s)-2-[(2-methyl-2-sulfanylpropanoyl)amino]-3-sulfanylpropanoic acid Chemical compound CC(C)(S)C(=O)N[C@H](CS)C(O)=O VUAFHZCUKUDDBC-SCSAIBSYSA-N 0.000 description 1
ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 description 1
ULVDFHLHKNJICZ-QCWLDUFUSA-N (4e)-4-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]methoxyimino]-4-phenylbutanoic acid Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1COC(C=C1)=CC=C1CO\N=C(/CCC(O)=O)C1=CC=CC=C1 ULVDFHLHKNJICZ-QCWLDUFUSA-N 0.000 description 1
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
FAFVVBJEQCPDIA-UHFFFAOYSA-N 1-[4-amino-2,6-di(propan-2-yl)phenyl]-3-[1-butyl-4-[3-(3-hydroxypropoxy)phenyl]-2-oxo-1,8-naphthyridin-3-yl]urea;hydrochloride Chemical compound Cl.CC(C)C=1C=C(N)C=C(C(C)C)C=1NC(=O)NC=1C(=O)N(CCCC)C2=NC=CC=C2C=1C1=CC=CC(OCCCO)=C1 FAFVVBJEQCPDIA-UHFFFAOYSA-N 0.000 description 1
TXIIZHHIOHVWJD-UHFFFAOYSA-N 2-[7-(2,2-dimethylpropanoylamino)-4,6-dimethyl-1-octyl-2,3-dihydroindol-5-yl]acetic acid Chemical compound CC(C)(C)C(=O)NC1=C(C)C(CC(O)=O)=C(C)C2=C1N(CCCCCCCC)CC2 TXIIZHHIOHVWJD-UHFFFAOYSA-N 0.000 description 1
NSVFSAJIGAJDMR-UHFFFAOYSA-N 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate Chemical compound CC=1NC(C)=C(C(=O)OCCN(CC=2C=CC=CC=2)C=2C=CC=CC=2)C(C=2C=C(C=CC=2)[N+]([O-])=O)C=1P1(=O)OCC(C)(C)CO1 NSVFSAJIGAJDMR-UHFFFAOYSA-N 0.000 description 1
PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
FSKFPVLPFLJRQB-UHFFFAOYSA-N 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-1-propanone Chemical compound C=1C=C(C)C=CC=1C(=O)C(C)CN1CCCCC1 FSKFPVLPFLJRQB-UHFFFAOYSA-N 0.000 description 1
IETKPTYAGKZLKY-UHFFFAOYSA-N 5-[[4-[(3-methyl-4-oxoquinazolin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione Chemical compound N=1C2=CC=CC=C2C(=O)N(C)C=1COC(C=C1)=CC=C1CC1SC(=O)NC1=O IETKPTYAGKZLKY-UHFFFAOYSA-N 0.000 description 1
RZTAMFZIAATZDJ-HNNXBMFYSA-N 5-o-ethyl 3-o-methyl (4s)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC(Cl)=C1Cl RZTAMFZIAATZDJ-HNNXBMFYSA-N 0.000 description 1
206010002383 Angina Pectoris Diseases 0.000 description 1
XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
ZKFQEACEUNWPMT-UHFFFAOYSA-N Azelnidipine Chemical compound CC(C)OC(=O)C1=C(C)NC(N)=C(C(=O)OC2CN(C2)C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZKFQEACEUNWPMT-UHFFFAOYSA-N 0.000 description 1
BWSSMIJUDVUASQ-UHFFFAOYSA-N Benzylhydrochlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1NC2CC1=CC=CC=C1 BWSSMIJUDVUASQ-UHFFFAOYSA-N 0.000 description 1
229940127291 Calcium channel antagonist Drugs 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
208000006029 Cardiomegaly Diseases 0.000 description 1
206010008111 Cerebral haemorrhage Diseases 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
KJEBULYHNRNJTE-DHZHZOJOSA-N Cinalong Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC\C=C\C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 KJEBULYHNRNJTE-DHZHZOJOSA-N 0.000 description 1
239000004470 DL Methionine Substances 0.000 description 1
208000007342 Diabetic Nephropathies Diseases 0.000 description 1
JFKJWWJOCJHMGV-WCCKRBBISA-N Ethyl L-cysteine hydrochloride Chemical compound Cl.CCOC(=O)[C@@H](N)CS JFKJWWJOCJHMGV-WCCKRBBISA-N 0.000 description 1
206010018364 Glomerulonephritis Diseases 0.000 description 1
229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
206010019280 Heart failures Diseases 0.000 description 1
206010022489 Insulin Resistance Diseases 0.000 description 1
229920010126 Linear Low Density Polyethylene (LLDPE) Polymers 0.000 description 1
IRLWJILLXJGJTD-UHFFFAOYSA-N Muraglitazar Chemical compound C1=CC(OC)=CC=C1OC(=O)N(CC(O)=O)CC(C=C1)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 IRLWJILLXJGJTD-UHFFFAOYSA-N 0.000 description 1
WGZDBVOTUVNQFP-UHFFFAOYSA-N N-(1-phthalazinylamino)carbamic acid ethyl ester Chemical compound C1=CC=C2C(NNC(=O)OCC)=NN=CC2=C1 WGZDBVOTUVNQFP-UHFFFAOYSA-N 0.000 description 1
OKJHGOPITGTTIM-DEOSSOPVSA-N Naveglitazar Chemical compound C1=CC(C[C@H](OC)C(O)=O)=CC=C1OCCCOC(C=C1)=CC=C1OC1=CC=CC=C1 OKJHGOPITGTTIM-DEOSSOPVSA-N 0.000 description 1
ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 1
TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 description 1
RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
229960000528 amlodipine Drugs 0.000 description 1
HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 description 1
206010003119 arrhythmia Diseases 0.000 description 1
230000006793 arrhythmia Effects 0.000 description 1
229960005370 atorvastatin Drugs 0.000 description 1
229950004646 azelnidipine Drugs 0.000 description 1
IWVTXAGTHUECPN-ANBBSHPLSA-N bacampicillin hydrochloride Chemical compound [H+].[Cl-].C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)[C@H](C(S3)(C)C)C(=O)OC(C)OC(=O)OCC)=CC=CC=C1 IWVTXAGTHUECPN-ANBBSHPLSA-N 0.000 description 1
229960005412 bacampicillin hydrochloride Drugs 0.000 description 1
229960002992 barnidipine Drugs 0.000 description 1
VXMOONUMYLCFJD-DHLKQENFSA-N barnidipine Chemical compound C1([C@@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)O[C@@H]2CN(CC=3C=CC=CC=3)CC2)=CC=CC([N+]([O-])=O)=C1 VXMOONUMYLCFJD-DHLKQENFSA-N 0.000 description 1
229950007003 benzylhydrochlorothiazide Drugs 0.000 description 1
229960004272 bucillamine Drugs 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
239000000292 calcium oxide Substances 0.000 description 1
ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
239000002775 capsule Substances 0.000 description 1
JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 description 1
229960001668 cefuroxime Drugs 0.000 description 1
206010008118 cerebral infarction Diseases 0.000 description 1
229960005110 cerivastatin Drugs 0.000 description 1
SEERZIQQUAZTOL-ANMDKAQQSA-N cerivastatin Chemical compound COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 SEERZIQQUAZTOL-ANMDKAQQSA-N 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229960003020 cilnidipine Drugs 0.000 description 1
238000004581 coalescence Methods 0.000 description 1
229910052681 coesite Inorganic materials 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
229910052593 corundum Inorganic materials 0.000 description 1
229910052906 cristobalite Inorganic materials 0.000 description 1
239000013078 crystal Substances 0.000 description 1
239000002781 deodorant agent Substances 0.000 description 1
238000013461 design Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 1
208000033679 diabetic kidney disease Diseases 0.000 description 1
GJQPMPFPNINLKP-UHFFFAOYSA-N diclofenamide Chemical compound NS(=O)(=O)C1=CC(Cl)=C(Cl)C(S(N)(=O)=O)=C1 GJQPMPFPNINLKP-UHFFFAOYSA-N 0.000 description 1
229960005081 diclofenamide Drugs 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000002934 diuretic Substances 0.000 description 1
229940030606 diuretics Drugs 0.000 description 1
229950003102 efonidipine Drugs 0.000 description 1
229940061262 ethyl cysteine hydrochloride Drugs 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
229960001596 famotidine Drugs 0.000 description 1
XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
229960003580 felodipine Drugs 0.000 description 1
239000000835 fiber Substances 0.000 description 1
229960002390 flurbiprofen Drugs 0.000 description 1
SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
229960003765 fluvastatin Drugs 0.000 description 1
238000005187 foaming Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229960002003 hydrochlorothiazide Drugs 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
238000002372 labelling Methods 0.000 description 1
230000007774 longterm Effects 0.000 description 1
229960003963 manidipine Drugs 0.000 description 1
ANEBWFXPVPTEET-UHFFFAOYSA-N manidipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(CC2)C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ANEBWFXPVPTEET-UHFFFAOYSA-N 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
235000006109 methionine Nutrition 0.000 description 1
239000010445 mica Substances 0.000 description 1
229910052618 mica group Inorganic materials 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
201000009925 nephrosclerosis Diseases 0.000 description 1
PKWDZWYVIHVNKS-UHFFFAOYSA-N netoglitazone Chemical compound FC1=CC=CC=C1COC1=CC=C(C=C(CC2C(NC(=O)S2)=O)C=C2)C2=C1 PKWDZWYVIHVNKS-UHFFFAOYSA-N 0.000 description 1
229960001783 nicardipine Drugs 0.000 description 1
229960001597 nifedipine Drugs 0.000 description 1
HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
229960004872 nizatidine Drugs 0.000 description 1
230000009965 odorless effect Effects 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
238000012858 packaging process Methods 0.000 description 1
229950003510 pactimibe Drugs 0.000 description 1
239000003973 paint Substances 0.000 description 1
239000000123 paper Substances 0.000 description 1
239000008188 pellet Substances 0.000 description 1
238000009512 pharmaceutical packaging Methods 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
229960002508 pindolol Drugs 0.000 description 1
PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 description 1
229960002797 pitavastatin Drugs 0.000 description 1
VGYFMXBACGZSIL-MCBHFWOFSA-N pitavastatin Chemical compound OC(=O)C[C@H](O)C[C@H](O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 VGYFMXBACGZSIL-MCBHFWOFSA-N 0.000 description 1
229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 1
239000002985 plastic film Substances 0.000 description 1
229920006255 plastic film Polymers 0.000 description 1
229920002493 poly(chlorotrifluoroethylene) Polymers 0.000 description 1
229920000139 polyethylene terephthalate Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229960002965 pravastatin Drugs 0.000 description 1
TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 description 1
238000003825 pressing Methods 0.000 description 1
238000000275 quality assurance Methods 0.000 description 1
229960001520 ranitidine hydrochloride Drugs 0.000 description 1
GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 description 1
XMSXOLDPMGMWTH-UHFFFAOYSA-N rivoglitazone Chemical compound CN1C2=CC(OC)=CC=C2N=C1COC(C=C1)=CC=C1CC1SC(=O)NC1=O XMSXOLDPMGMWTH-UHFFFAOYSA-N 0.000 description 1
229950010764 rivoglitazone Drugs 0.000 description 1
229960004586 rosiglitazone Drugs 0.000 description 1
229960000672 rosuvastatin Drugs 0.000 description 1
BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000007789 sealing Methods 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
229960002855 simvastatin Drugs 0.000 description 1
RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
239000002356 single layer Substances 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 1
229940084026 sodium valproate Drugs 0.000 description 1
229910052682 stishovite Inorganic materials 0.000 description 1
238000003860 storage Methods 0.000 description 1
229960001940 sulfasalazine Drugs 0.000 description 1
NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
229960005349 sulfur Drugs 0.000 description 1
OPYGFNJSCUDTBT-PMLPCWDUSA-N sultamicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(=O)OCOC(=O)[C@H]2C(S(=O)(=O)[C@H]3N2C(C3)=O)(C)C)(C)C)=CC=CC=C1 OPYGFNJSCUDTBT-PMLPCWDUSA-N 0.000 description 1
229960001636 sultamicillin tosylate Drugs 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
CXGTZJYQWSUFET-IBGZPJMESA-N tesaglitazar Chemical compound C1=CC(C[C@H](OCC)C(O)=O)=CC=C1OCCC1=CC=C(OS(C)(=O)=O)C=C1 CXGTZJYQWSUFET-IBGZPJMESA-N 0.000 description 1
OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
229950001089 todralazine Drugs 0.000 description 1
229960005334 tolperisone Drugs 0.000 description 1
229960004813 trichlormethiazide Drugs 0.000 description 1
LMJSLTNSBFUCMU-UHFFFAOYSA-N trichlormethiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NC(C(Cl)Cl)NS2(=O)=O LMJSLTNSBFUCMU-UHFFFAOYSA-N 0.000 description 1
229910052905 tridymite Inorganic materials 0.000 description 1
229960004453 trimethadione Drugs 0.000 description 1
IRYJRGCIQBGHIV-UHFFFAOYSA-N trimethadione Chemical compound CN1C(=O)OC(C)(C)C1=O IRYJRGCIQBGHIV-UHFFFAOYSA-N 0.000 description 1
208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
229910001845 yogo sapphire Inorganic materials 0.000 description 1
239000011787 zinc oxide Substances 0.000 description 1
229910001928 zirconium oxide Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
- B01J20/16—Alumino-silicates
- B01J20/18—Synthetic zeolitic molecular sieves
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
- B65D81/266—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
- B65D81/267—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants the absorber being in sheet form

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Mechanical Engineering (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Composite Materials (AREA)
Inorganic Chemistry (AREA)
Analytical Chemistry (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Food Science & Technology (AREA)
Wrappers (AREA)
Packages (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

JP2008540976A 2006-10-25 2007-10-22 包装材 Active JP5241503B2 (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP2008540976A JP5241503B2 (ja)	2006-10-25	2007-10-22	包装材

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP2006290033		2006-10-25
JP2006290033		2006-10-25
JP2008540976A JP5241503B2 (ja)	2006-10-25	2007-10-22	包装材
PCT/JP2007/070539 WO2008050714A1 (fr)	2006-10-25	2007-10-22	Matériel de conditionnement

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2013024058A Division JP5546072B2 (ja)	2006-10-25	2013-02-12	包装材

Publications (2)

Publication Number	Publication Date
JPWO2008050714A1 JPWO2008050714A1 (ja)	2010-02-25
JP5241503B2 true JP5241503B2 (ja)	2013-07-17

Family

ID=39324511

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP2008540976A Active JP5241503B2 (ja)	2006-10-25	2007-10-22	包装材
JP2013024058A Active JP5546072B2 (ja)	2006-10-25	2013-02-12	包装材

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2013024058A Active JP5546072B2 (ja)	2006-10-25	2013-02-12	包装材

Country Status (5)

Country	Link
JP (2)	JP5241503B2 (zh)
KR (1)	KR101400653B1 (zh)
CN (1)	CN101528179B (zh)
TW (2)	TWI486183B (zh)
WO (1)	WO2008050714A1 (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5500164B2 (ja) *	2009-03-02	2014-05-21	アステラス製薬株式会社	固形製剤の包装体
EP2612827A4 (en) *	2010-09-01	2014-10-22	Astellas Pharma Inc	PACKAGING
WO2012029323A1 (ja) *	2010-09-01	2012-03-08	共同印刷株式会社	積層体、包装容器、及び包装体
CN102152543A (zh) *	2010-12-14	2011-08-17	郑勇	具有铝箔漫反射面金属光泽的聚乙烯镀铝薄膜
JP5671397B2 (ja) *	2011-03-30	2015-02-18	共同印刷株式会社	蓋材，包装容器及び包装体
MX352703B (es) *	2012-03-01	2017-12-05	Maruho Kk	Paquete de producto medicinal.
JP5849001B2 (ja) *	2012-03-23	2016-01-27	第一三共株式会社	Ｐｔｐ又はブリスターパック用積層体、及びこれを用いて成形されたｐｔｐ又はブリスターパック
TW201347988A (zh) *	2012-03-23	2013-12-01	Daiichi Sankyo Co Ltd	Ptp或泡殼包裝用積層體及ptp或泡殼包裝
JP6421404B2 (ja) *	2013-05-31	2018-11-14	大日本印刷株式会社	医薬品包装体
GB2538255B (en)	2015-05-12	2020-02-26	Innovia Films Ltd	Film for packaging
JP6927663B2 (ja) *	2015-10-23	2021-09-01	ニプロ株式会社	固形製剤包装体、及び固形製剤の臭い除去方法
KR102503428B1 (ko) *	2015-12-22	2023-02-24	한미약품 주식회사	두타스테라이드를 포함하는 경구용 연질 캡슐 제형용 포장재
JP2018090298A (ja) *	2016-12-05	2018-06-14	小林製薬株式会社	ブリスターパッケージ
EP3381548A1 (en) *	2017-03-31	2018-10-03	Clariant International Ltd	Adsorbent and packaging material
JP6958030B2 (ja) *	2017-07-04	2021-11-02	大日本印刷株式会社	低臭気積層体と該積層体からなる包装材料、及び該積層体の製造方法
JP6992358B2 (ja) *	2017-09-22	2022-01-13	大日本印刷株式会社	低臭気積層体と該積層体からなる包装材料、及び該積層体の製造方法
JP7143614B2 (ja) *	2018-03-30	2022-09-29	大日本印刷株式会社	臭気吸着積層体及び臭気吸着性包装材料
CN111918932B (zh) *	2018-03-30	2023-06-30	大日本印刷株式会社	异味吸附成型品树脂组合物、异味吸附成型品以及包装材料
CN109467848A (zh) *	2018-11-07	2019-03-15	温州莲华环保科技有限公司	一种高吸附功能膜及其制备方法
JP7233213B2 (ja) *	2018-12-13	2023-03-06	共同印刷株式会社	ブリスターパック用積層体、それを用いたブリスターパック、及びブリスターパック包装体
CN110589228A (zh) *	2019-08-02	2019-12-20	中山火炬职业技术学院	一种异味固体的密封包装工艺
JP7162363B2 (ja) *	2020-09-29	2022-10-28	Ｍｉｃｓ化学株式会社	積層フィルムおよび袋体

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05230794A (ja) *	1991-10-28	1993-09-07	Eka Nobel Ab	包装材料、その製造方法、ならびにその使用
JPH08104370A (ja) *	1994-10-04	1996-04-23	Kishimoto Akira	調理食品包装容器
JPH08197692A (ja) *	1995-01-30	1996-08-06	Dainippon Printing Co Ltd	ガスバリヤー積層材
JP2006028496A (ja) *	2004-06-18	2006-02-02	Toyo Seikan Kaisha Ltd	臭気捕捉用樹脂組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0624571B2 (ja) *	1988-11-21	1994-04-06	明治製菓株式会社	医薬品包装容器
US20040116025A1 (en) *	2002-12-17	2004-06-17	Gogins Mark A.	Air permeable garment and fabric with integral aerosol filtration
CN1271068C (zh) *	2003-03-25	2006-08-23	上海医药工业研究院	一种奥美沙坦酯的制备方法
JP4659523B2 (ja) *	2005-04-26	2011-03-30	共同印刷株式会社	ブリスター用フィルム及びブリスター用包装容器
KR101318032B1 (ko) *	2005-05-20	2013-10-14	다이이찌 산쿄 가부시키가이샤	필름 코팅 제제
KR101314439B1 (ko) *	2005-05-20	2013-10-07	다이이찌 산쿄 가부시키가이샤	덱스트로오스 함유 필름 코팅 제제

2007
- 2007-10-22 CN CN2007800395199A patent/CN101528179B/zh active Active
- 2007-10-22 KR KR1020097006803A patent/KR101400653B1/ko active IP Right Grant
- 2007-10-22 WO PCT/JP2007/070539 patent/WO2008050714A1/ja active Application Filing
- 2007-10-22 JP JP2008540976A patent/JP5241503B2/ja active Active
- 2007-10-23 TW TW102113345A patent/TWI486183B/zh active
- 2007-10-23 TW TW096139646A patent/TWI402085B/zh active
2013
- 2013-02-12 JP JP2013024058A patent/JP5546072B2/ja active Active

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05230794A (ja) *	1991-10-28	1993-09-07	Eka Nobel Ab	包装材料、その製造方法、ならびにその使用
JPH08104370A (ja) *	1994-10-04	1996-04-23	Kishimoto Akira	調理食品包装容器
JPH08197692A (ja) *	1995-01-30	1996-08-06	Dainippon Printing Co Ltd	ガスバリヤー積層材
JP2006028496A (ja) *	2004-06-18	2006-02-02	Toyo Seikan Kaisha Ltd	臭気捕捉用樹脂組成物

Also Published As

Publication number	Publication date
TW201332594A (zh)	2013-08-16
JPWO2008050714A1 (ja)	2010-02-25
CN101528179B (zh)	2013-06-26
TWI402085B (zh)	2013-07-21
TWI486183B (zh)	2015-06-01
CN101528179A (zh)	2009-09-09
WO2008050714A1 (fr)	2008-05-02
KR20090074754A (ko)	2009-07-07
JP2013121535A (ja)	2013-06-20
JP5546072B2 (ja)	2014-07-09
TW200824728A (en)	2008-06-16
KR101400653B1 (ko)	2014-05-27

Publication	Publication Date	Title
JP5241503B2 (ja)	2013-07-17	包装材
JP6175425B2 (ja)	2017-08-02	Ｐｔｐ又はブリスターパック用積層体及びｐｔｐ又はブリスターパック
JP4659523B2 (ja)	2011-03-30	ブリスター用フィルム及びブリスター用包装容器
CA2664380C (en)	2016-08-23	Medicinal package
JP2009545343A (ja)	2009-12-24	医薬製剤を含むパック
EP3312004B1 (en)	2020-09-02	Laminate for use in blister pack, and blister pack using same
JP2019010775A (ja)	2019-01-24	吸湿及びガス吸着用フィルム、並びに包装用積層体
JP6832715B2 (ja)	2021-02-24	包装袋及びその製造方法
JP2017012975A (ja)	2017-01-19	吸湿及びガス吸着用フィルム
JP6811622B2 (ja)	2021-01-13	吸湿及びガス吸着用フィルム並びに包装用積層体
JP6832714B2 (ja)	2021-02-24	包装袋及びその製造方法
JP7252592B2 (ja)	2023-04-05	包装材
JP2018115010A (ja)	2018-07-26	吸湿及びガス吸着用フィルム並びに包装用積層体
JP6902862B2 (ja)	2021-07-14	ブリスターパック用積層体、及びそれを用いたブリスターパック
JP7233213B2 (ja)	2023-03-06	ブリスターパック用積層体、それを用いたブリスターパック、及びブリスターパック包装体
JP2019089561A5 (zh)	2020-08-27
JP2018008729A (ja)	2018-01-18	包装材
JP6927663B2 (ja)	2021-09-01	固形製剤包装体、及び固形製剤の臭い除去方法
JP2019010768A (ja)	2019-01-24	吸湿及びガス吸着用フィルム、並びに包装用積層体

Legal Events

Date	Code	Title	Description
2010-10-15	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101014
2012-07-12	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120711
2012-09-04	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120903
2012-11-14	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20121113
2013-02-13	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130212
2013-02-21	A911	Transfer to examiner for re-examination before appeal (zenchi)	Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20130220
2013-03-22	TRDD	Decision of grant or rejection written
2013-03-27	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130326
2013-04-11	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130402
2013-04-12	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20160412 Year of fee payment: 3
2013-04-12	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5241503 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150
2016-03-15	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2017-03-14	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2018-03-13	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2019-03-19	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2020-03-11	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2021-03-11	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2022-03-11	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2023-03-13	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2024-03-13	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250